4.6 Article

Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Neurological complications of acute ischaemic stroke

Joyce S. Balami et al.

LANCET NEUROLOGY (2011)

Review Clinical Neurology

Astrocytes: biology and pathology

Michael V. Sofroniew et al.

ACTA NEUROPATHOLOGICA (2010)

Review Biochemistry & Molecular Biology

Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders

William M. Armstead et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Review Clinical Neurology

Microglial Activation in Stroke: Therapeutic Targets

Midori A. Yenari et al.

NEUROTHERAPEUTICS (2010)

Article Pediatrics

Comparison of two neonatal ischemic injury models using magnetic resonance imaging

Stephen Ashwal et al.

PEDIATRIC RESEARCH (2007)

Article Ophthalmology

Synergistic effect of platelet-activating factor and tumor necrosis factor-α on corneal myofibroblast apoptosis

JC He et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)

Article Neurosciences

Lipid signaling in neural plasticity, brain repair, and neuroprotection

NG Bazan

MOLECULAR NEUROBIOLOGY (2005)

Article Ophthalmology

Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist

S Esquenazi et al.

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2004)